Cargando…

Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease

BACKGROUND: Prostate-specific antigen (PSA) screening for prostate cancer results in a large number of unnecessary prostate biopsies. There is a need for specific molecular markers that can be used in combination with PSA to improve the specificity of PSA screening. We examined GADD45a methylation i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reis, I M, Ramachandran, K, Speer, C, Gordian, E, Singal, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522641/ https://www.ncbi.nlm.nih.gov/pubmed/26171936 http://dx.doi.org/10.1038/bjc.2015.240

Ejemplares similares

A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions
por: Xu, Z-q, et al.
Publicado: (2013)

Expression of pendrin in benign and malignant human thyroid tissues
por: Skubis-Zegadło, J, et al.
Publicado: (2005)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Pleural fluid analysis of lung cancer vs benign inflammatory disease patients
por: Kremer, R, et al.
Publicado: (2010)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Effects of growth arrest and DNA damage-inducible protein 34 (GADD34) on inflammation-induced colon cancer in mice
por: Tanaka, Yuriko, et al.
Publicado: (2015)

The role of Gadd45b in neurologic and neuropsychiatric disorders: An overview
por: Shen, Xiao-yue, et al.
Publicado: (2022)

Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
por: Kraan, J, et al.
Publicado: (2014)

An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
por: Ahmed, N, et al.
Publicado: (2008)

Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Huang, Jiaqi, et al.
Publicado: (2016)

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours
por: Karger, S, et al.
Publicado: (2012)

Gadd45β and Gadd45γ are critical for regulating autoimmunity
por: Liu, Lin, et al.
Publicado: (2005)

DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
por: Paziewska, A, et al.
Publicado: (2014)

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
por: Huhtinen, K, et al.
Publicado: (2009)

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study
por: Van den Eynden, G G, et al.
Publicado: (2006)

Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer
por: Kuefer, R, et al.
Publicado: (2005)

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures
por: Sandanayake, N S, et al.
Publicado: (2011)

Isolation of tumour stem-like cells from benign tumours
por: Xu, Q, et al.
Publicado: (2009)

Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma
por: Hotta, K, et al.
Publicado: (2011)

Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma
por: Birgersdotter, A, et al.
Publicado: (2009)

MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers
por: Zhang, P, et al.
Publicado: (2010)

Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
por: Mead, R, et al.
Publicado: (2011)

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations
por: Pinato, D J, et al.
Publicado: (2013)

Double-edged Gadd45
por: Powell, Kendall
Publicado: (2005)

Gadd45 in stress signaling
por: Liebermann, Dan A, et al.
Publicado: (2008)

Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study
por: Larkin, S E T, et al.
Publicado: (2016)

MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma
por: Padrão, Nuno André, et al.
Publicado: (2017)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
por: Mahon, K L, et al.
Publicado: (2014)

Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate
por: Elkahwaji, J E, et al.
Publicado: (2009)

Malignant melanoma and bone resorption
por: Lau, Y S, et al.
Publicado: (2006)

The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
por: Kilvaer, Thomas K, et al.
Publicado: (2016)

Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications
por: Gakiopoulou, H, et al.
Publicado: (2007)

GADD45a and GADD45b Genes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
por: Li, Ruei-Nian, et al.
Publicado: (2019)

Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)
por: Houssami, N, et al.
Publicado: (2007)

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues
por: Riddick, A C P, et al.
Publicado: (2005)

A humanised anti-IGF-1R monoclonal antibody (AVE1642) enhances Bortezomib-induced apoptosis in myeloma cells lacking CD45
por: Descamps, G, et al.
Publicado: (2009)

Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping study
por: Horsch, M, et al.
Publicado: (2009)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Azacitidine regulates DNA methylation of GADD45γ in myelodysplastic syndromes
por: Yang, Yanli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tqsn38sjs9vtgstbhseu0re3p1